Werewolf Therapeutics Inc

HOWLNASDAQ · USD
0.99USD0.00 (+0.76%)
4510

Werewolf Therapeutics Inc (HOWL) Straddle

No qualifying straddle setups were found for HOWL in the prior session.

Read more

Trading a HOWL straddle lets you take a pure volatility position on Werewolf Therapeutics Inc without committing to a direction. Werewolf Therapeutics Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate HOWL straddle pricing in real time and find the moments when expected moves are mispriced.

A long straddle on HOWL profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Werewolf Therapeutics Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the HOWL straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.

Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of relapsed or refractory advanced or metastatic solid tumors or lymphoma.

The company is also developing WTX-613, a conditionally activated interferon alpha INDUKINE molecule for the treatment of solid tumors and hematologic malignancies. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.

Earnings, product cycles, macro prints — any time volatility itself is the trade, the HOWL straddle is the cleanest expression of that view. Our scanner prices every HOWL straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a HOWL straddle into a catalyst or short a HOWL straddle to harvest decay, the options straddle setups that matter are all in one place.

No illustrative rows to display.

As of September 23, 2026

Find the right straddle before volatility moves

Track HOWL straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.

Start your 14-day free trial